Loading organizations...
RPR Venture operated as a venture capital firm, directing investments towards the healthcare sector from its Seattle, Washington base. The firm backed early-stage companies, providing capital to fuel innovation and growth within medical and biotechnology. Its investment approach focused on identifying key advancements and market needs, supporting novel solutions.
Established in Seattle, RPR Venture was founded by individuals with a shared vision for advancing healthcare through strategic investment. Its inception stemmed from an insight into the critical need for specialized capital and guidance to scale innovative ventures within the burgeoning healthcare industry, forming an entity dedicated to impacting patient care.
The firm's portfolio comprised healthcare enterprises, from biotechnology startups to medical device innovators, leveraging RPR Venture's capital to accelerate development and market penetration. RPR Venture envisioned fostering a robust healthcare innovation ecosystem, ultimately aiming to improve patient outcomes and reshape medical treatment's future through strategic investments.
RPR Venture has 1 tracked investment across 1 company. The latest tracked deal is $5.5M Series B in LumiThera in October 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 31, 2017 | LumiThera | $5.5M Series B | Yang Yigang | — |